BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pezzilli R, Campana D, Morselli-Labate AM, Fabbri MC, Brocchi E, Tomassetti P. Patient-reported outcomes in subjects with neuroendocrine tumors of the pancreas. World J Gastroenterol 2009; 15(40): 5067-5073 [PMID: 19860000 DOI: 10.3748/wjg.15.5067]
URL: https://www.wjgnet.com/1007-9327/full/v15/i40/5067.htm
Number Citing Articles
1
Caroline Martini, Eva-Maria Gamper, Lisa Wintner, Bernhard Nilica, Barbara Sperner-Unterweger, Bernhard Holzner, Irene Virgolini. Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumoursHealth and Quality of Life Outcomes 2016; 14(1) doi: 10.1186/s12955-016-0527-2
2
Eleonora Lauricella, Mauro Cives, Alessandra Bracigliano, Ottavia Clemente, Valentina Felici, Rossella Lippolis, Brunella Amoruso, Eleonora Pelle', Barbara Mandriani, Chiara Esposto, Cira Forte, Francesco Perri, Camillo Porta, Salvatore Tafuto. The psychological impact of COVID‐19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerabilityJournal of Neuroendocrinology 2021; 33(10) doi: 10.1111/jne.13041
3
Aaron I. Vinik, Eric Raymond. Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinibTherapeutic Advances in Gastroenterology 2013; 6(5) doi: 10.1177/1756283X13493878
4
Rohit Gosain, Medhavi Gupta, Arya Mariam Roy, Jonathan Strosberg, Kathryn M. Glaser, Renuka Iyer. Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic ReviewCancers 2022; 14(6) doi: 10.3390/cancers14061428
5
Michael A. Erdek, Lauren M. King, Susannah G. Ellsworth. Pain management and palliative care in pancreatic cancerCurrent Problems in Cancer 2013; 37(5) doi: 10.1016/j.currproblcancer.2013.10.003
6
Lisa Guccione, Karla Gough, Allison Drosdowsky, Krista Fisher, Timothy Price, Nick Pavlakis, Mustafa Khasraw, David Wyld, David Ransom, Grace Kong, Megan Rogers, Simone Leyden, John Leyden, Michael Michael, Penelope Schofield. Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based InterventionJMIR Research Protocols 2019; 8(12) doi: 10.2196/14361
7
P. Jiménez-Fonseca, A. Carmona-Bayonas, E. Martín-Pérez, G. Crespo, R. Serrano, M. Llanos, C. Villabona, R. García-Carbonero, J. Aller, J. Capdevila, E. Grande. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumorsCancer and Metastasis Reviews 2015; 34(3) doi: 10.1007/s10555-015-9573-1
8
Melissa Frangie Machado, Niloofar Masoumi, Leila Azari, Megan Centrella, Kami Mukenschnabl, Yu Chen Lin, Pamela Hodul, Jessica Y. Islam, Kea Turner, Amir Alishahi Tabriz. Depression as a potential early indicator of pancreatic cancer: a systematic review of prevalence, mechanisms, and temporal associationsJournal of Psychosocial Oncology 2026;  doi: 10.1080/07347332.2026.2679587
9
Anna Stickel, Antonia Pallauf, Ute Goerling. Neuroendokrine Tumoren aus psychoonkologischer Sicht – ein ÜberblickDer Onkologe 2018; 24(2) doi: 10.1007/s00761-017-0320-9
10
Donna Fountain, Oscar R Leeuwenkamp, Rajaventhan Srirajaskanthan, John K Ramage, Craig William Tallentire, Catherine Watson. Quality of life in patients with gastroenteropancreatic tumours: A systematic literature reviewWorld Journal of Gastroenterology 2020; 26(25): 3686-3711 doi: 10.3748/wjg.v26.i25.3686
11
Vic Velanovich, Ira Wollner. Quality of life and performance status in patients with pancreatic and periampullary tumorsInternational Journal of Clinical Oncology 2011; 16(4) doi: 10.1007/s10147-011-0200-z
12
Aurélien Lambert, Lilian Schwarz, Ivan Borbath, Aline Henry, Jean-Luc Van Laethem, David Malka, Michel Ducreux, Thierry Conroy. An update on treatment options for pancreatic adenocarcinomaTherapeutic Advances in Medical Oncology 2019; 11 doi: 10.1177/1758835919875568
13
Thierry Almont, Corinne Couteau, Hélène Etienne, Pierre Bondil, Rosine Guimbaud, Leslie Schover, Éric Huyghe. Sexual health and needs for sexology care in digestive cancer patients undergoing chemotherapy: a 4-month cross-sectional study in a French University HospitalSupportive Care in Cancer 2018; 26(8) doi: 10.1007/s00520-018-4125-1
14
Anna La Salvia, Alberto Portigliatti Pomeri, Irene Persano, Elena Trevisi, Elena Parlagreco, Nicoletta Colombi, Maria Pia Brizzi, Rocco Luigi Picci, Francesco Oliva. Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping reviewComprehensive Psychiatry 2021; 109 doi: 10.1016/j.comppsych.2021.152244
15
Beatriz Febrero, Esmeralda Teruel, Inmaculada Ros‐Madrid, Pedro Segura, José M. Rodríguez. The Influence of the Clinical, Therapeutic and Socio‐Personal Profile on the Quality of Life of Patients With Multiple Endocrine Neoplasia Type 1World Journal of Surgery 2025; 49(4) doi: 10.1002/wjs.12522
16
Jared R. Adams, David Ray, Renee Willmon, Sonia Pulgar, Arvind Dasari. Living With Neuroendocrine Tumors: Assessment of Quality of Life Through a Mobile ApplicationJCO Clinical Cancer Informatics 2019; (3) doi: 10.1200/CCI.19.00025
17
I. Chau, R. Casciano, J. Willet, X. Wang, J.C. Yao. Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: a systematic reviewEuropean Journal of Cancer Care 2013; 22(6) doi: 10.1111/ecc.12085
18
Daniela Mirandola, Giovanna Franchi, Alice Maruelli, Manuela Vinci, Maria Grazia Muraca, Guido Miccinesi, Mirko Manetti, Mirca Marini. Tailored Sailing Experience to Reduce Psychological Distress and Improve the Quality of Life of Breast Cancer Survivors: A Survey-Based Pilot StudyInternational Journal of Environmental Research and Public Health 2020; 17(12) doi: 10.3390/ijerph17124406
19
Shu-Fen Su, Shu-Ni Lin, Chia-Sui Chen. Self-Efficacy Care Program for Older Adults Receiving Hip-Fracture SurgeryClinical Nursing Research 2021; 30(6) doi: 10.1177/10547738211001486
20
Jennifer L. Beaumont, David Cella, Alexandria T. Phan, Seung Choi, Zhimei Liu, James C. Yao. Comparison of Health-Related Quality of Life in Patients With Neuroendocrine Tumors With Quality of Life in the General US PopulationPancreas 2012; 41(3) doi: 10.1097/MPA.0b013e3182328045
21
Nicole Ann E Villa, Gina Maria P Fiore, Eduardo D Espiridion. Exploring the Link Between Pancreatic Neuroendocrine Tumors and Depression: A Case StudyCureus 2023;  doi: 10.7759/cureus.44363
22
Andrew D. Boyd, Doris Brown, Chris Henrickson, Janet Hampton, Bin Zhu, Farideh Almani, Edgar Ben-Josef, Mark Zalupski, Diane M. Simeone, Jeremy M. G. Taylor, Roseanne Armitage, Michelle Riba. Screening for Depression, Sleep-Related Disturbances, and Anxiety in Patients with Adenocarcinoma of the Pancreas: A Preliminary StudyThe Scientific World Journal 2012; 2012 doi: 10.1100/2012/650707
23
Vic Velanovich. The Association of Quality-of-Life Measures With Malignancy and Survival in Patients With Pancreatic PathologyPancreas 2011; 40(7) doi: 10.1097/MPA.0b013e31821ad8eb
24
Aaron I. Vinik, Etta Vinik, Anne Diebold, Eugene Woltering. Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract2014;  doi: 10.1007/978-2-8178-0430-9_14
25
John K. Ramage, Pankaj Punia, Olusola Faluyi, Andrea Frilling, Tim Meyer, Ruby Saharan, Juan W. Valle. Observational Study to Assess Quality of Life in Patients with Pancreatic Neuroendocrine Tumors Receiving Treatment with Everolimus: The OBLIQUE Study (UK Phase IV Trial)Neuroendocrinology 2019; 108(4) doi: 10.1159/000497330
26
Lili Song, Yanshuo Cao, Jie Li, Ming Lu, Lili Tang. Psychological distress and resilience in patients with gastroenteropancreatic neuroendocrine tumorFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.947998
27
Margaret R. Bauer, Emma E. Bright, James J. MacDonald, Elizabeth H. Cleary, O. Joe Hines, Annette L. Stanton. Quality of Life in Patients With Pancreatic Cancer and Their CaregiversPancreas 2018; 47(4) doi: 10.1097/MPA.0000000000001025
28
Soon Khai Low, Dimitrios Giannis, Nourelhoda Sami Bahaie, Bao Long Hoang Trong, Dimitrios Moris, Nguyen Tien Huy. Competing Mortality in Patients With Neuroendocrine TumorsAmerican Journal of Clinical Oncology 2019; 42(8) doi: 10.1097/COC.0000000000000575
29
Giardini Anna, Pisoni Camilla, Giorgi Ines, Borelli Veronica, Scoccia Elisabetta, Majani Giuseppina. ICF, quality of life, and depression in breast cancer: perceived disability in disease-free women 6 months after mastectomySupportive Care in Cancer 2013; 21(9) doi: 10.1007/s00520-013-1794-7
30
Trude Haugland, Holli A. DeVon. Symptoms, Psychosocial Factors, and Health-Related Quality of Life in Patients With Neuroendocrine TumorsCancer Nursing 2019; 42(4) doi: 10.1097/NCC.0000000000000614
31
Oleg O. Kolyago, Adele A. Munirova, Stanislav V. Ivanov, Ivan S. Stilidi. Mental disorders of the depressive and anxiety spectrum in neuroendocrine tumors: prevalence, pathogenesis, clinical particularsAlmanac of Clinical Medicine 2024; 52(3) doi: 10.18786/2072-0505-2024-52-015
32
Shenghong Sun, Wei Wang, Chiyi He, Ilaria Peluso. Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry‐Based AnalysisOxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/9985814
33
Anthony DeSomma, Sebastian Maletz, Toni L. Basinski, Raiza Morales, Tiago Biachi de Castria, Mark Bloomston, Dung-Tsa Chen, Wade G. Douglas, Kevin L. Huguet, Daniel Jeong, Kun Jiang, Dae Won Kim, Anjuli Luthra, Jose M. Pimiento, Sahana Rajasekhara, Vic Velanovich, Margaret A. Park, Grant S. Shields, George M. Slavich, Jennifer B. Permuth. Lifetime stressor exposure and depression among patients with pancreatic cancer: insights from the Florida Pancreas CollaborativeBMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-15007-w